$iShares Global Clean Energy ETF(ICLN)$In the latest US infrastructure and tax bill, there was a share in clean energy."Tax credits for clean energy investment and setting clean energy standards, aiming at reducing carbon emissions in the power sector by 80% and reducing the negotiation volume of the whole economy by 50% by 2030; Impose import duties on polluters"Thought this would be a bullish signal for clean energy.
@hydros:$SINGTEL(Z74.SI)$by dbs research1QFY22 numbers are towards the upper end of our expectations• Singtel's 1QF22F underlying net profit of S$451m (+31% y-o-y) was towards the upper end of our estimate of S$430m-S$450m• Sharp recovery in Australia, profit turnaround of Bharti and stabilization of Singapore were key drivers. • Maintain BUY with unchanged TP of S$3.01 for over 28% upside potential and 3.6% yieldSingtel's 1QF22F underlying net profit of S$451m (+31% y-o-y) was towards the upper end of our estimate of S$430m-S$450m and comprised 22% of our full year estimate. What stood out was a big rise in Australia consumer operating profit to S$44m (excluding National Broadband Network migration revenue) compared to S$26m in 4Q21 and operating loss of
Ritlecitinib is a small molecule for oral treatment of ulcerative colitis, alopecia, areata, vitiligo and Crohn's disease.It's an inhibitor of Janus kinases 3 and TEC family kinase.